Matrix metalloproteinase inhibitors (MMPIs): The beginning of phase I or the termination of phase III clinical trials
- 1 January 2003
- journal article
- review article
- Published by Springer Nature in Cancer and Metastasis Reviews
- Vol. 22 (2/3) , 177-203
- https://doi.org/10.1023/a:1023047431869
Abstract
The decade of the 1990s was ripe with enthusiasm for the use of MMPIs to treat cancer. Limitations to new cytotoxic chemotherapy approaches to treat solid cancers and a better understanding of tumor...Keywords
This publication has 0 references indexed in Scilit: